"On Feb. 24, 2014, the U.S. Food and Drug Administration approved Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired "...
REGRANEX Gel is contraindicated in patients with known neoplasm(s) at the site(s) of application.
Last reviewed on RxList: 5/25/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Regranex Information
Regranex - User Reviews
Regranex User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find tips and advances in treatment.